300
Participants
Start Date
August 1, 2024
Primary Completion Date
April 30, 2027
Study Completion Date
July 31, 2027
Intravenous thrombolysis + edaravone
The patient underwent intravenous t-PA thrombolysis and sublingual administration of edaravone tablets in the prehospital ambulance. Intravenous t-PA thrombolysis was performed in accordance with international guidelines: t-PA dose was calculated according to 0.9mg/kg; 10% of the total dose was injected intravenously, and the remaining 90% was administered intravenously at a uniform rate within one hour.
IV thrombolysis + placebo (control group)
Patients underwent intravenous t-PA thrombolysis + placebo sublingual administration. The method of intravenous t-PA thrombolysis is in accordance with the international guideline standards: t-PA dose is calculated according to 0.9mg/kg; 10% of the total dose is injected intravenously, and the remaining 90% is administered intravenously at a constant rate within 1 hour.
RECRUITING
Beijing Tiantan Hospital of Capital Medical University, Beijing
Xing'an League People's Hospital
UNKNOWN
Suzhou First People's Hospital
UNKNOWN
Nanyang nanshi Hospital
UNKNOWN
Nanjing Baixinyu Pharmaceutical Co., Ltd.
UNKNOWN
Ruijun Ji
OTHER